Therma Bright Inc V.THRM

Alternate Symbol(s): TBRIF

Healthcare Medical Devices

Therma Bright Inc. is a developer and partner in a range of diagnostic and medical device technologies. It focuses on providing consumers and medical professionals with solutions that address medical and healthcare challenges. It is involved in developing, acquiring, manufacturing, and marketing proprietary healthcare and medical devices for the consumer and institutional marketplace. Its product offerings include Covid-19 diagnostic test product line, such as AcuVid COVID-19 Rapid Antigen Saliva Test and AcuVid COVID-19 Rapid Antibody Test; Sores & Bite Inflammation Therapy product line, such as InterceptCS Cold Sore Prevention System and TherOZap, and Muscle Pain & Blood Circulation Health Therapy product line, such as Venowave, which is a circulation booster designed to improve circulation in the lower extremities. The Venowave is a medical compression pump that is lightweight, compact, battery operated, designed to treat and alleviate the symptoms associated with poor circulation.

TSXV:THRM - Post by User

Therma Bright Inc > FDA requesting clinical performance study.

<< Previous

Bullboard Posts

Next >>

Comment by hemi3tcon Oct 28, 2021 1:21pm

70 Views

Post# 34059684

RE:FDA requesting clinical performance study.

was good in Brazil with high chance of getting a person with a high viral load. now going to the USA where infection rates are lower. chances og missing all the low viral loads is high.

Kaiser wrote:
“conduct a point-of-care clinical performance study". The way I read this is the clinical data submitted must be good as the next stage is to put the device to a test in a live setting.

Not sure why everyone is panicking lol. The data was good. My only question and concern is can this be completed within 3 weeks.